Similar to the effect of BRCA1/2 mutations in hereditary breast and ovarian cancer, BRCA1/2 variants have been shown to be moderately elevated to increase PCa risk across populations (108). This evidence concerns the gene BRCA1 and posterior cortical atrophy.